Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 16,112,000 | 15,775,000 | 14,631,000 | 15,962,000 | 15,035,000 |
Cost of Goods | 3,745,000 | 3,540,000 | 3,912,000 | 4,264,000 | 4,024,000 |
Gross Profit | 12,367,000 | 12,235,000 | 10,719,000 | 11,698,000 | 11,011,000 |
Operating Expenses | 6,239,000 | 6,475,000 | 12,431,000 | 5,826,000 | 16,023,000 |
Operating Income | 6,128,000 | 5,760,000 | -1,712,000 | 5,872,000 | -5,012,000 |
Other Income | -122,000 | -90,000 | -334,000 | -252,000 | -323,000 |
Pre-tax Income | 6,006,000 | 5,670,000 | -2,046,000 | 5,620,000 | -5,335,000 |
Income Tax | 545,000 | 903,000 | -820,000 | 870,000 | 637,000 |
Net Income Continuous | 5,461,000 | 4,767,000 | -1,226,000 | 4,750,000 | -5,972,000 |
Minority Interests | 6,000 | 5,000 | N/A | 5,000 | 3,000 |
Net Income | $5,455,000 | $4,762,000 | $-1,226,000 | $4,745,000 | $-5,975,000 |
EPS Basic Total Ops | 2.15 | 1.88 | -0.49 | 1.87 | -2.35 |
EPS Basic Continuous Ops | 2.16 | 1.88 | -0.49 | 1.87 | -2.35 |
EPS Diluted Total Ops | 2.14 | 1.87 | -0.48 | 1.86 | -2.35 |
EPS Diluted Continuous Ops | 2.15 | 1.87 | -0.48 | 1.87 | -2.35 |
EPS Diluted Before Non-Recurring Items | 2.28 | 2.07 | 0.03 | 2.13 | -2.06 |
EBITDA(a) | $7,260,000 | $6,744,000 | $-748,000 | $6,886,000 | $-4,109,000 |